ArticleAJPM focus2026
Mobilizing Community-Driven Public Health: Increasing Access to Diagnostic Testing for Underserved Individuals Through Lab-In-A-Van Partnerships.
Article in AJPM focus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Underrepresented populations, who often have the highest need for accessible health care, frequently face barriers to accessing services. To address health inequities, researchers evaluated a community-informed lab-in-a-van model that was designed to increase access to COVID-19 testing for vulnerable populations. Methods: Free saliva-based SARS-CoV-2 diagnostic testing was offered between June 2023 and July 2024 at 123 events in Connecticut, U.S., using a Clinical Laboratory Improvement Amendments-certified mobile laboratory. Approximately 100 local leaders and organizations informed the program's design. After providing samples, participants completed an IRB-approved survey; responses were stored using REDCap. Results: Offering on-site testing helped remove barriers and increased access for traditionally underserved communities. Overall, 1,428 individuals were tested, and 838 completed a testing experience survey. Of the respondents, 54% identified as Black, Indigenous, People of Color; 59% reported an annual household income <$25,000; and 31% were uninsured. Participants reported that the service was easy to access (74%) and comfortable to use (75%); 29% received their first COVID-19 test, and 48% were unaware of alternative testing options. Results were reported in an average of 3.1 hours, enabling many participants to receive their diagnostic results during the community event; 48 positive samples were identified. Conclusions: This program evaluation demonstrates that community-informed mobile testing programs capable of delivering same-day diagnostic results can expand access to testing among underserved populations and may represent a scalable strategy for improving diagnostic access during future public health emergencies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.